Chinook Therapeutics Inc

NASDAQ:KDNY   4:00:00 PM EDT
22.56
-0.21 (-0.92%)
4:01:51 PM EDT: $22.56 0.00 (0.00%)
Earnings Announcements

Chinook Therapeutics Inc Reports Q3 EPS Of $0.83

Published: 11/10/2022 21:09 GMT
Chinook Therapeutics Inc (KDNY) - Chinook Therapeutics Provides Business Update and Reports Third Quarter 2022 Financial Results.
Chinook Therapeutics Inc - Qtrly EPS $0.83.
Revenue is expected to be $0.11 Million
Adjusted EPS is expected to be -$0.79

Next Quarter Revenue Guidance is expected to be $0.08 Million
Next Quarter EPS Guidance is expected to be -$0.78

More details on our Analysts Page.